Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind PK/PD study of ceftriamidine sodium for injection in community-acquired bacterial pneumonia
CTR20241088Phase 2Completed
- Sponsor
- Baiyunshan Pharmaceutical General Factory
- Start
- Nov 2024
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ceftriamidine in community acquired pneumonia (CAP), sponsored by Baiyunshan Pharmaceutical General Factory. Started Nov 2024; status: completed.
02
Drugs
ceftriamidine
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on CTR20241088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241088.